Cite
Banerjee S, Mahmud F, Deng S, et al. X-ray Crystallography-Guided Design, Antitumor Efficacy, and QSAR Analysis of Metabolically Stable Cyclopenta-Pyrimidinyl Dihydroquinoxalinone as a Potent Tubulin Polymerization Inhibitor. J Med Chem. 2021;64(17):13072-13095doi: 10.1021/acs.jmedchem.1c01202.
Banerjee, S., Mahmud, F., Deng, S., Ma, L., Yun, M. K., Fakayode, S. O., Arnst, K. E., Yang, L., Chen, H., Wu, Z., Lukka, P. B., Parmar, K., Meibohm, B., White, S. W., Wang, Y., Li, W., & Miller, D. D. (2021). X-ray Crystallography-Guided Design, Antitumor Efficacy, and QSAR Analysis of Metabolically Stable Cyclopenta-Pyrimidinyl Dihydroquinoxalinone as a Potent Tubulin Polymerization Inhibitor. Journal of medicinal chemistry, 64(17), 13072-13095. https://doi.org/10.1021/acs.jmedchem.1c01202
Banerjee, Souvik, et al. "X-ray Crystallography-Guided Design, Antitumor Efficacy, and QSAR Analysis of Metabolically Stable Cyclopenta-Pyrimidinyl Dihydroquinoxalinone as a Potent Tubulin Polymerization Inhibitor." Journal of medicinal chemistry vol. 64,17 (2021): 13072-13095. doi: https://doi.org/10.1021/acs.jmedchem.1c01202
Banerjee S, Mahmud F, Deng S, Ma L, Yun MK, Fakayode SO, Arnst KE, Yang L, Chen H, Wu Z, Lukka PB, Parmar K, Meibohm B, White SW, Wang Y, Li W, Miller DD. X-ray Crystallography-Guided Design, Antitumor Efficacy, and QSAR Analysis of Metabolically Stable Cyclopenta-Pyrimidinyl Dihydroquinoxalinone as a Potent Tubulin Polymerization Inhibitor. J Med Chem. 2021 Sep 09;64(17):13072-13095. doi: 10.1021/acs.jmedchem.1c01202. Epub 2021 Aug 18. PMID: 34406768.
Copy
Download .nbib